澳股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

醫藥生物股

650.237

-4.347-0.66%

漲家數：15

跌家數：10

平家數：20

市盈率：- -

高：656.360

開：654.803

低：647.137

收：654.584

成交量：3,253.73萬

成交額：8,494.85萬

市值：972.18億

流通市值：941.66億

資料載入中...

Mayne Pharma - ASIC正式批准公司將2025年股東大會的召開時間從11月28日或之前延長至1月30日或之前

澳大利亞收購委員會 - Mayne尋求最終命令，包括Cosette同意將 FIRB 的決定法定截止日期延長至12月1日

澳大利亞收購委員會 - Mayne尋求臨時命令，包括Cosette向委員會確認將與Firb會面

Mesoblast將於下月與FDA會談討論Rexlemestrocel-L和阿片類藥物戒斷

Mesoblast將於下月與FDA會面討論Rexlemestrocel-L和藥物戒斷

Bioxyne Ltd - 與Curaleaf International簽署澳大利亞獨家進口、製造和供應協議

澳大利亞財政部長考慮阻止科賽特競購後，梅因製藥股價大跌

梅因製藥股價下跌至38.6%，因澳大利亞財政部長考慮阻止收購要約

CSL LIMITED - CSL Seqirus與疫苗工業公司與衞生部簽署重要諒解備忘錄

Opthea Ltd - 預計於2025年11月10日左右向美國證券交易委員會提交25號表格以實施退市

葛蘭素史克抗癌、抗艾滋病藥物銷售額提升，2025 年前景看好，股價大漲

美國市場動盪不安，澳大利亞 CSL 公司推遲分拆疫苗部門

CSL Ltd - 先前提出的拆分時間推進將無法充分體現Seqirus的價值潛力

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK7508/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"醫藥生物股","latestPrice":650.2372,"timestamp":1762745474781,"preClose":654.584,"halted":0,"volume":32537257,"delay":0,"changeRate":-0.006641,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-4.346802,"latestTime":"11-10 14:31:15 AEDT","open":654.80316,"high":656.3603,"low":647.13666,"amount":84948487,"amplitude":0.014091,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1762750800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1762729200000,1762750800000]],"turnoverRate":0.001249,"increases":16,"decrements":10,"flats":18,"marketCap":97217885681.5,"floatMarketCap":94165918138.625},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":656.3603,"amplitude":0.014091,"preClose":654.584,"low":647.13666,"latestPrice":650.2372,"volume":32537257,"delay":0,"open":654.80316,"prevYearClose":936.801,"prevWeekClose":654.584,"prevMonthClose":662.953,"prevQuarterClose":712.826,"fiveDayClose":650.95,"twentyDayClose":751.072,"sixtyDayClose":937.392,"secType":"PLATE","market":"AU","turnoverRate":0.001249,"marketCap":97217885681.5,"floatMarketCap":94165918138.625,"timestamp":1762745474781,"nameCN":"醫藥生物股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":15,"down":10,"flat":20},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1199687473","title":"Mayne Pharma - ASIC正式批准公司將2025年股東大會的召開時間從11月28日或之前延長至1月30日或之前","url":"https://stock-news.laohu8.com/highlight/detail?id=1199687473","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199687473?lang=zh_tw&edition=fundamental","pubTime":"2025-11-07 14:46","pubTimestamp":1762497972,"startTime":"0","endTime":"0","summary":"Mayne Pharma - ASIC正式批准公司将2025年股东大会的召开时间从11月28日或之前延长至1月30日或之前","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","BK7508","MYX.AU"],"gpt_icon":0},{"id":"1180672738","title":"澳大利亞收購委員會 - Mayne尋求最終命令，包括Cosette同意將 FIRB 的決定法定截止日期延長至12月1日","url":"https://stock-news.laohu8.com/highlight/detail?id=1180672738","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180672738?lang=zh_tw&edition=fundamental","pubTime":"2025-11-06 15:35","pubTimestamp":1762414512,"startTime":"0","endTime":"0","summary":"澳大利亚收购委员会 - Mayne寻求最终命令，包括Cosette同意将 FIRB 的决定法定截止日期延长至12月1日","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MYX.AU","BK7096"],"gpt_icon":0},{"id":"1130202281","title":"澳大利亞收購委員會 - Mayne尋求臨時命令，包括Cosette向委員會確認將與Firb會面","url":"https://stock-news.laohu8.com/highlight/detail?id=1130202281","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130202281?lang=zh_tw&edition=fundamental","pubTime":"2025-11-06 15:34","pubTimestamp":1762414452,"startTime":"0","endTime":"0","summary":"澳大利亚收购委员会 - Mayne寻求临时命令，包括Cosette向委员会确认将与Firb会面","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MYX.AU","BK7096"],"gpt_icon":0},{"id":"1116191251","title":"Mesoblast將於下月與FDA會談討論Rexlemestrocel-L和阿片類藥物戒斷","url":"https://stock-news.laohu8.com/highlight/detail?id=1116191251","media":"投资观察","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116191251?lang=zh_tw&edition=fundamental","pubTime":"2025-11-05 09:45","pubTimestamp":1762307124,"startTime":"0","endTime":"0","summary":"11月5日（路透社） - Mesoblast Ltd：*MESOBLAST将于下月与FDA会面，讨论Rexlemestrocel-L和阿片类药物戒断* 进一步公司报道：MSB.AX","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","MSB.AU","BK7501","BK7508"],"gpt_icon":0},{"id":"1199521939","title":"Mesoblast將於下月與FDA會面討論Rexlemestrocel-L和藥物戒斷","url":"https://stock-news.laohu8.com/highlight/detail?id=1199521939","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199521939?lang=zh_tw&edition=fundamental","pubTime":"2025-11-05 06:59","pubTimestamp":1762297168,"startTime":"0","endTime":"0","summary":"Mesoblast将于下月与FDA会面，讨论Rexlemestrocel-L和药物戒断的相关事宜。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MESO","BK7501","MSB.AU","BK7067","BK4139"],"gpt_icon":0},{"id":"1136919449","title":"Bioxyne Ltd - 與Curaleaf International簽署澳大利亞獨家進口、製造和供應協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1136919449","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136919449?lang=zh_tw&edition=fundamental","pubTime":"2025-11-03 05:30","pubTimestamp":1762119009,"startTime":"0","endTime":"0","summary":"Bioxyne Ltd - 与Curaleaf International签署澳大利亚独家进口、制造和供应协议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7111","BXN.AU","BK7508"],"gpt_icon":0},{"id":"2579766456","title":"澳大利亞財政部長考慮阻止科賽特競購後，梅因製藥股價大跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2579766456","media":"路透中文","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579766456?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 17:18","pubTimestamp":1761902334,"startTime":"0","endTime":"0","summary":"更新 1-澳大利亚财政部长考虑阻止科赛特竞购后，梅因制药股价大跌财政部长称收购可能违背国家利益据媒体报导，珂赛特关闭梅恩阿德莱德工厂的计划可能导致200个工作岗位流失投资者警告称，该决定可能阻碍澳大利亚未来的并购交易重铸并通过Scott Murdoch路透10月31日 - 周五，梅恩制药MYX.AX的股价暴跌近三分之一，因为有消息称澳大利亚财政部长正在考虑阻止现在不情愿的收购方Cosette Pharmaceuticals对该公司提出的6.72亿澳元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nL4T3WC0TC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7096","BK7508"],"gpt_icon":0},{"id":"1193649617","title":"梅因製藥股價下跌至38.6%，因澳大利亞財政部長考慮阻止收購要約","url":"https://stock-news.laohu8.com/highlight/detail?id=1193649617","media":"美股速递","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193649617?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 07:25","pubTimestamp":1761866710,"startTime":"0","endTime":"0","summary":"梅因制药的股价下跌至38.6%，原因是澳大利亚财政部长考虑是否阻止该公司的收购要约。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","BK7508","MYX.AU"],"gpt_icon":0},{"id":"1185215746","title":"CSL LIMITED - CSL Seqirus與疫苗工業公司與衞生部簽署重要諒解備忘錄","url":"https://stock-news.laohu8.com/highlight/detail?id=1185215746","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185215746?lang=zh_tw&edition=fundamental","pubTime":"2025-10-30 13:55","pubTimestamp":1761803711,"startTime":"0","endTime":"0","summary":"CSL LIMITED - CSL Seqirus与疫苗工业公司与卫生部签署重要谅解备忘录","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","CSL.AU","BK7508","BK7511","BK7501"],"gpt_icon":0},{"id":"1148005890","title":"Opthea Ltd - 預計於2025年11月10日左右向美國證券交易委員會提交25號表格以實施退市","url":"https://stock-news.laohu8.com/highlight/detail?id=1148005890","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148005890?lang=zh_tw&edition=fundamental","pubTime":"2025-10-30 06:32","pubTimestamp":1761777148,"startTime":"0","endTime":"0","summary":"Opthea Ltd - 预计于2025年11月10日左右向美国证券交易委员会提交25号表格以实施退市","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OPT.AU","BK7508","BK7067"],"gpt_icon":0},{"id":"2579204689","title":"葛蘭素史克抗癌、抗艾滋病藥物銷售額提升，2025 年前景看好，股價大漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2579204689","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579204689?lang=zh_tw&edition=fundamental","pubTime":"2025-10-29 17:24","pubTimestamp":1761729849,"startTime":"0","endTime":"0","summary":"更新版 1-更新 2-葛兰素史克抗癌、抗艾滋病药物销售额提升，2025 年前景看好，股价大涨股价上涨近 4%，达到 2024 年 5 月以来的最高水平 即将离任的首席执行官沃姆斯利在本季度表现强劲 非美国市场推动疫苗销售增长添加领涨股票、图表和美国疫苗销售详情Bhanvi Satija/Yadarisa Shabong. 美国疫苗销售压力 葛兰素史克表示，在截至9月30日的季度里，公司疫苗销售总额达到26.8亿英镑，高于分析师预测的25.5亿英镑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nL4T3WA0XE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU0225771236.USD","LU1670756490.USD","LU1098665638.USD","GSK.UK","BK5011","LU0971552673.USD","BK7511","IE00BWDBJ516.SGD","LU1035777561.USD","LU1481599808.USD","LU0225284248.USD","LU1481600234.SGD","LU1400636491.USD","BK7501","LU1309081286.SGD","BK7067","LU1487256676.USD","IE00BQJZX424.USD","LU0321505439.SGD","LU1400636574.HKD","LU0971552830.HKD","LU1015430645.USD","LU0211331839.USD","LU1064927863.SGD","LU0109981661.USD","LU0575583348.USD","LU1302929846.USD","CSL.AU","LU0545562505.USD","LU1228905037.USD","LU0289739699.SGD","LU0306806265.USD","LU0203347892.USD","LU0306807586.USD","LU1400636657.SGD","LU0321505868.SGD","LU0985481810.HKD","IE0034235071.USD","LU1046248800.SGD","LU1202635105.USD","LU0161305163.EUR","BK7508","LU1645745479.HKD","LU1228905540.USD","LU0203345920.USD"],"gpt_icon":0},{"id":"2578740406","title":"美國市場動盪不安，澳大利亞 CSL 公司推遲分拆疫苗部門","url":"https://stock-news.laohu8.com/highlight/detail?id=2578740406","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578740406?lang=zh_tw&edition=fundamental","pubTime":"2025-10-28 06:23","pubTimestamp":1761603803,"startTime":"0","endTime":"0","summary":"美国市场动荡不安，澳大利亚 CSL 公司推迟分拆疫苗部门路透10月27日 - 澳大利亚生物技术公司CSL CSL.AX周二表示，由于美国流感疫苗市场波动加剧，该公司不再以在2026财年完成疫苗部门的分拆为目标。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nL4S3W81OY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7067","BK7501","BK7508","CSL.AU"],"gpt_icon":0},{"id":"1194146757","title":"CSL Ltd - 先前提出的拆分時間推進將無法充分體現Seqirus的價值潛力","url":"https://stock-news.laohu8.com/highlight/detail?id=1194146757","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194146757?lang=zh_tw&edition=fundamental","pubTime":"2025-10-28 06:12","pubTimestamp":1761603128,"startTime":"0","endTime":"0","summary":"CSL Ltd - 先前提出的拆分时间推进将无法充分体现Seqirus的价值潜力","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK7508","BK7501","BK7067","BK7511"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":13,"code":"91000000","status":"200"}]}}